The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Dipna Pharmachem Ltd

Dipna Pharmachem Ltd

BSE 543594 · NSE DPL · ISIN INE0MC401013 · Group M · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹5.31

-2.03%

BSE close, 28 August 2026

Market cap

₹13.96 cr

2.6 cr shares · Micro cap

Free float

₹12.02 cr

as published

P/E · P/B

6.8× · —

EPS ₹0.78 · BV —

FY25-26 rev / PAT

129.08 / 2.63

₹ cr, as filed

Filings, window

1

0 selected · 0%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹3.90 52-WK HIGH ₹25.00 ₹5.31 7% of range
Against 52-week high-78.8%
Against 52-week low+36.2%
Day change-2.03%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹0.78
Price / earnings6.81×
Price / book—
Book value — derived, price ÷ P/B—
Return on equity—
Operating margin—
Net margin—

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Sep-25 · Q 72.33 1.41 0.59 4.02% 1.95%
Mar-25 · Q 34.29 0.64 0.27 5.75% 1.86%
FY25-26 129.08 2.63 1.00 3.89% 2.04%

Quarter on quarter

Revenue, quarter on quarter
+110.9%
Net profit, quarter on quarter
+120.3%
Operating margin, quarter on quarter
-173 bps

Disclosure profile 1 filings in the window

0 median 17.0 p75 · 25 sector max 52 1 1th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Procedural
Trading Window1
Procedural sub-total1
Total1

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group M, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

1 filings · 0 selected · busiest 2026-09-30

Filings

1 in the window · 13 earlier on record

  1. 30 September 2026 ·

    Trading Window

    Closure of Trading Window

    Intimation of Closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

RSS feed for Dipna Pharmachem Ltd · the 50 most recent filings